FILE PHOTO: An employee of the vaccine company Bavarian Nordic works in a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. REUTERS/Lukas Barth/File Photo
FILE PHOTO: An employee of the vaccine company Bavarian Nordic works in a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. REUTERS/Lukas Barth/File Photo